关注
Maximilian CCJC Ebert
Maximilian CCJC Ebert
Congruence Therapeutics
在 umontreal.ca 的电子邮件经过验证
标题
引用次数
引用次数
年份
Identification of 3-chymotrypsin like protease (3CLPro) inhibitors as potential anti-SARS-CoV-2 agents
V Mody, J Ho, S Wills, A Mawri, L Lawson, MC Ebert, GM Fortin, ...
Communications biology 4 (1), 93, 2021
2262021
Roles of TRPM2 in oxidative stress
N Takahashi, D Kozai, R Kobayashi, M Ebert, Y Mori
Cell calcium 50 (3), 279-287, 2011
1932011
Computational tools for enzyme improvement: why everyone can–and should–use them
MC Ebert, JN Pelletier
Current Opinion in Chemical Biology 37, 89-96, 2017
1022017
Fragment-based design of symmetrical bis-benzimidazoles as selective inhibitors of the trimethoprim-resistant, type II R67 dihydrofolate reductase
D Bastien, MC Ebert, D Forge, J Toulouse, N Kadnikova, F Perron, ...
Journal of Medicinal Chemistry 55 (7), 3182-3192, 2012
322012
O2-dependent protein internalization underlies astrocytic sensing of acute hypoxia by restricting multimodal TRPA1 channel responses
M Uchiyama, A Nakao, Y Kurita, I Fukushi, K Takeda, T Numata, HN Tran, ...
Current Biology 30 (17), 3378-3396. e7, 2020
302020
Enzyme engineering: A synthetic biology approach for more effective library generation and automated high-throughput screening
D Quaglia, MC Ebert, PF Mugford, JN Pelletier
PLoS One 12 (2), e0171741, 2017
292017
Transnitrosylation directs TRPA1 selectivity in N-nitrosamine activators
D Kozai, Y Kabasawa, M Ebert, S Kiyonaka, Y Otani, T Numata, ...
Molecular pharmacology 85 (1), 175-185, 2014
292014
Aloin isoforms (A and B) selectively inhibits proteolytic and deubiquitinating activity of papain like protease (PLpro) of SARS-CoV-2 in vitro
DSM Lewis, J Ho, S Wills, A Kawall, A Sharma, K Chavada, MC Ebert, ...
Scientific reports 12 (1), 2145, 2022
282022
Monitoring protein conformational changes using fluorescent nanoantennas
SG Harroun, D Lauzon, MC Ebert, A Desrosiers, X Wang, A Vallée-Bélisle
Nature Methods 19 (1), 71-80, 2022
222022
The structural dynamics of engineered β-lactamases vary broadly on three timescales yet sustain native function
SMC Gobeil, MC Ebert, J Park, D Gagné, N Doucet, AM Berghuis, J Pleiss, ...
Scientific Reports 9 (1), 6656, 2019
222019
AMBER free energy tools: a new framework for the design of optimized alchemical transformation pathways
HC Tsai, TS Lee, A Ganguly, TJ Giese, MC Ebert, P Labute, KM Merz Jr, ...
Journal of Chemical Theory and Computation 19 (2), 640-658, 2023
212023
Substrate-specific screening for mutational hotspots using biased molecular dynamics simulations
MC Ebert, J Guzman Espinola, G Lamoureux, JN Pelletier
Acs Catalysis 7 (10), 6786-6797, 2017
212017
Evolution of P450 monooxygenases toward formation of transient channels and exclusion of nonproductive gases
MC Ebert, SL Dürr, A A. Houle, G Lamoureux, JN Pelletier
Acs Catalysis 6 (11), 7426-7437, 2016
212016
Indigo formation and rapid NADPH consumption provide robust prediction of raspberry ketone synthesis by engineered cytochrome P450 BM3
O Rousseau, MC Ebert, D Quaglia, A Fendri, AH Parisien, JN Besna, ...
ChemCatChem 12 (3), 837-845, 2020
152020
Asymmetric mutations in the tetrameric R67 dihydrofolate reductase reveal high tolerance to active‐site substitutions
MC Ebert, KL Morley, JP Volpato, AR Schmitzer, JN Pelletier
Protein Science 24 (4), 495-507, 2015
132015
Dual-target inhibitors of the folate pathway inhibit intrinsically trimethoprim-resistant DfrB dihydrofolate reductases
JL Toulouse, G Shi, C Lemay-St-Denis, MC Ebert, D Deon, M Gagnon, ...
ACS medicinal chemistry letters 11 (11), 2261-2267, 2020
122020
Structure-based design of dimeric bisbenzimidazole inhibitors to an emergent trimethoprim-resistant type II dihydrofolate reductase guides the design of monomeric analogues
JL Toulouse, BJ Yachnin, EH Ruediger, D Deon, M Gagnon, ...
ACS omega 4 (6), 10056-10069, 2019
102019
Novel crystallization conditions for tandem variant R67 DHFR yield a wild-type crystal structure
BJ Yachnin, DY Colin, JP Volpato, M Ebert, JN Pelletier, AM Berghuis
Acta Crystallographica Section F: Structural Biology and Crystallization …, 2011
92011
Identification of 3-chymotrypsin like protease (3CLPro) inhibitors as potential anti-SARS-CoV-2 agents. Commun Biol 4: 1–10
V Mody, J Ho, S Wills, A Mawri, L Lawson, MC Ebert, GM Fortin, ...
82021
ATP synthase: a moonlighting enzyme with unprecedented functions
JN Vigneau, P Fahimi, M Ebert, Y Cheng, C Tannahill, P Muir, ...
Chemical Communications 58 (16), 2650-2653, 2022
72022
系统目前无法执行此操作,请稍后再试。
文章 1–20